Alexandre Gaymard1, Maude Bouscambert-Duchamp2, Maxime Pichon2, Emilie Frobert2, Julien Vallee3, Bruno Lina2, Jean-Sébastien Casalegno2, Florence Morfin2. 1. Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux (IAI) de Lyon, Centre National de Référence des virus respiratoires France Sud, Centre de Biologie et de Pathologie Nord, Groupement Hospitalier Nord, F-69317 Lyon, France; Université de Lyon, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France. Electronic address: alexandre.gaymard@chu-lyon.fr. 2. Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux (IAI) de Lyon, Centre National de Référence des virus respiratoires France Sud, Centre de Biologie et de Pathologie Nord, Groupement Hospitalier Nord, F-69317 Lyon, France; Université de Lyon, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, F-69372 Lyon, France. 3. Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux (IAI) de Lyon, Centre National de Référence des virus respiratoires France Sud, Centre de Biologie et de Pathologie Nord, Groupement Hospitalier Nord, F-69317 Lyon, France.
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is a well-recognized cause of respiratory tract infections. Based on G gene variations, 11 RSV-A and 36 RSV-B genotypes have been described to date. The ON1 genotype was detected in Ontario in 2010 and subsequently reported in several countries. OBJECTIVES: The objective of the present study was to investigate for the first time the RSV epidemiology and genotype diversity in France between 2010 and 2014. STUDY DESIGN: All respiratory samples received from patients with influenza-like illness or respiratory tract infection were screened for RSV infection by RT-PCR. The results were stratified according to winter season. Among the RSV-positive cases, 117 samples were further investigated for phylogenetic analysis out of 150 randomly selected for sequencing. RESULTS: Among the 20,359 cases screened, 14% of the cases were RSV-positive. RSV-A was predominant during the four winter seasons. The first ON1 variant was detected during the 2010-2011 winter and reached 85% of all RSV-A-positive cases in 2013-2014. Most RSV-B was classified as BA9 and BA10 genotypes but a new genotype (BA-Ly) was described. CONCLUSION: As reported in different countries, ON1 variants were firstly detected in 2011 and became the predominant RSV-A genotype in Lyon. Among RSV-B, BA9 was predominant but detected alongside BA10 or a transient genotype (BA-Ly).
BACKGROUND:Respiratory syncytial virus (RSV) is a well-recognized cause of respiratory tract infections. Based on G gene variations, 11 RSV-A and 36 RSV-B genotypes have been described to date. The ON1 genotype was detected in Ontario in 2010 and subsequently reported in several countries. OBJECTIVES: The objective of the present study was to investigate for the first time the RSV epidemiology and genotype diversity in France between 2010 and 2014. STUDY DESIGN: All respiratory samples received from patients with influenza-like illness or respiratory tract infection were screened for RSV infection by RT-PCR. The results were stratified according to winter season. Among the RSV-positive cases, 117 samples were further investigated for phylogenetic analysis out of 150 randomly selected for sequencing. RESULTS: Among the 20,359 cases screened, 14% of the cases were RSV-positive. RSV-A was predominant during the four winter seasons. The first ON1 variant was detected during the 2010-2011 winter and reached 85% of all RSV-A-positive cases in 2013-2014. Most RSV-B was classified as BA9 and BA10 genotypes but a new genotype (BA-Ly) was described. CONCLUSION: As reported in different countries, ON1 variants were firstly detected in 2011 and became the predominant RSV-A genotype in Lyon. Among RSV-B, BA9 was predominant but detected alongside BA10 or a transient genotype (BA-Ly).
Authors: Hessa A Al-Sharif; Sherif A El-Kafrawy; Jehad M Yousef; Taha A Kumosani; Mohammad A Kamal; Norah A Khathlan; Reham M Kaki; Abeer A Alnajjar; Esam I Azhar Journal: Genes (Basel) Date: 2020-11-09 Impact factor: 4.096
Authors: Giscard F Komoyo; Brice M Yambiyo; Alexandre Manirakiza; Jean C Gody; Claude P Muller; Judith M Hübschen; Emmanuel Nakoune; Chantal J Snoeck Journal: Health Sci Rep Date: 2021-05-11
Authors: Emma Sáez-López; Paula Cristóvão; Inês Costa; Pedro Pechirra; Patrícia Conde; Raquel Guiomar; Maria João Peres; Regina Viseu; Paulo Lopes; Vânia Soares; Fátima Vale; Patricia Fonseca; Ludivina Freitas; Jose Alves; Maria Ana Pessanha; Cristina Toscano; Luísa Mota-Vieira; Rita Cabral Veloso; Rita Côrte-Real; Paula Branquinho; João Pereira-Vaz; Fernando Rodrigues; Mário Cunha; Luís Martins; Paula Mota; Ana Rita Couto; Jácome Bruges-Armas; Sofia Almeida; Débora Rodrigues Journal: J Clin Virol Date: 2019-10-10 Impact factor: 3.168
Authors: M Jeannoël; G Lina; J P Rasigade; B Lina; F Morfin; Jean Sebastien Casalegno Journal: Eur J Clin Microbiol Infect Dis Date: 2018-10-23 Impact factor: 3.267
Authors: Nora Suleiman-Martos; Alberto Caballero-Vázquez; Jose Luis Gómez-Urquiza; Luis Albendín-García; Jose Luis Romero-Béjar; Guillermo A Cañadas-De la Fuente Journal: J Pers Med Date: 2021-05-15